TABLE 2.

Summary of the SUCRA of efficacy and high-grade side effects.

Outcome and data	AZA	DAC	CCR	p-value of the design-by-treatment test
Overall response rate	63.7	84.3	2.1	0.625
Complete remission	44.1	97.6	8.3	0.074
Partial remission	47.4	82.1	20.6	0.54
Complete remission with incomplete blood count recovery	6.39	85.9	0.2	0.553
Hematology improvement	64.7	55.4	29.8	0.876
Neutropenia	49.9	0.1	100	0.005
Thrombocytopenia	47.8	13	89.2	0.434
Anemia	96	4.9	49.1	0.037
Febrile neutropenia	97.1	0.3	62.7	0.009
Pneumonia	16.5	37.6	91.9	0.589
Leukopenia	86.6	0	63.4	0.002
Hypokalemia	82.8	24.7	42.5	0.324
Death	83	45.2	21.8	0.489

SUCRA, surface under the cumulative ranking curve.